Env-glycoprotein vaccine for protection of htlv-i and -ii...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/15 (2006.01) A61K 39/21 (2006.01) C07K 14/16 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2262007

The present invention relates to novel protein antigens derived from the HTLV env protein, that are capable of being used as a vaccine to aid in the prevention and treatment of HTLV-I and HTLV-II infections and novel methods for the production of such an antigen.

La présente invention concerne des nouveaux antigènes protéiniques, dérivés de la protéine d'enveloppe de HTLV (virus du lymphome humain à lymphocytes T), que l'on peut utiliser en tant que vaccin dans la prévention et le traitement d'infections à HTLV-I et HTLV-II; elle concerne également des nouveaux procédés de production d'un tel antigène.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Env-glycoprotein vaccine for protection of htlv-i and -ii... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Env-glycoprotein vaccine for protection of htlv-i and -ii..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Env-glycoprotein vaccine for protection of htlv-i and -ii... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1402101

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.